ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1482

Latent Tuberculosis Infection and Its Associations with Clinical and Serological Parameters in Systemic Lupus Erythematosus

Gayathri MS1, Chengappa Kavadichanda2, Aishwarya Gopal3, Devender Bairwa4, Molly Thabah1, Sonali Sarkar5 and Prakash Babu Narasimhan1, 1Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, Puducherry, India, 2JIPMER, Pondicherry, Puducherry, India, 3Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, Puducherry, India, 4Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, Puducherry, India, 5Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

Meeting: ACR Convergence 2022

Keywords: autoimmune diseases, Outcome measures, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: SLE – Diagnosis, Manifestations, and Outcomes Poster II: Manifestations

Session Type: Poster Session C

Session Time: 1:00PM-3:00PM

Background/Purpose: Latent tuberculosis infection (L-TB) detected by mycobacterium tuberculosis (TB) IFN-γ release assay (TB-IGRA), besides identifying latent infection may predict the disease status in SLE. Identifying the clinical and serological associations of LTB in lupus may be an important step in preventing progressing to overt TB in lupus. This is especially true in high endemic countries like India. This study aimed to assess the prevalence of L-TB, its association with clinical and serological parameters in SLE

Methods: This is a single center cross sectional study. Adults with SLE with no past h/o TB were recruited (n=219). Demography, disease activity indices, autoantibody profile and steroid use were noted. Presence of Latent TB was assessed in all patients using TB-IGRA. Based on the results of TB-IGRA, SLE cases were divided into 2 groups-IGRA positive and IGRA negative. The collected parameters were compared between the 2 groups. Correlation of disease activity was assessed with the IFN g levels in the unstimulated tube of TB IGRA to assess baseline immune activation in SLE.

Results: Among 219 patients, 41 had latent TB resulting in a point prevalence of 18.7 %. The average disease duration was 3 years in IGRA positive and 4.1 in IGRA negative group(p >0.05). Among antibody profile, proportion of Ro 52 was higher in IGRA positive group(43.9%)than IGRA negative group(25.3%) (p=0.014) and proportion aCLA IgM antibody higher in IGRA negative group (12.9%) than positive group (2.4%) (p=0.032). Comparison of clinical features yielded no statistically significant difference in the 2 groups. Serology revealed greater proportion of low C4 in IGRA negative as compared to the positive group(p=0.036). There was no correlation of SLE disease activity with the IFN g levels in the unstimulated tube of TB IGRA.

Conclusion: Prevalence of latent TB in SLE cases was 18.7% which is lesser than latent TB prevalence in the general population (40%). Higher association of anti-Ro 52 antibody in IGRA positive group along with higher aCLA IgM and low C4 in IGRA negative group were found whose physiological significance is unknown. IFNg levels in the unstimulated tube of TB IGRA did not seem to correlate with SLE disease activity. Further studies would be required to throw more light on the interplay between latent TB and SLE.

Supporting image 1

Comparison of clinical and laboratory parameters between IGRA positive and IGRA negative SLE cases


Disclosures: G. MS, None; C. Kavadichanda, None; A. Gopal, None; D. Bairwa, None; M. Thabah, None; S. Sarkar, None; P. Narasimhan, None.

To cite this abstract in AMA style:

MS G, Kavadichanda C, Gopal A, Bairwa D, Thabah M, Sarkar S, Narasimhan P. Latent Tuberculosis Infection and Its Associations with Clinical and Serological Parameters in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/latent-tuberculosis-infection-and-its-associations-with-clinical-and-serological-parameters-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/latent-tuberculosis-infection-and-its-associations-with-clinical-and-serological-parameters-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology